EBITDA's not as impressive as the NPAT, which is unusual... the R&D Tax Credit of about $6m means we have $9.3m NPAT, but only $3.7m EBITDA.
The maiden profit is a little more tempered with that info, but still, none of us are buying for the 2023 profit. The growth potential is excellent. Would've loved a projected FY24 somewhere in there.
Ann: February 2024 Investor Presentation, page-7
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DRO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
80.0¢ |
Change
-0.015(1.84%) |
Mkt cap ! $697.6M | |||
| Open | High | Low | Value | Volume |
| 80.0¢ | 82.0¢ | 78.0¢ | $11.80M | 14.81M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 171352 | 80.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 80.5¢ | 15000 | 1 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| DRO (ASX) Chart |